Quality of reporting of two-group parallel randomized controlled clinical trials of multi-herb formulae: A survey of reports indexed in the Science Citation Index Expanded

European Journal of Integrative Medicine

Volumn 3, Issue 4, 2011, Pages e309-e316

  Zhong, Yunqing ^a   Zhou, Wei ^a   Jiang, Hongli ^a   Fan, Tao ^a   Diao, Xiang ^a   Yang, Hongmei ^b   Min, Jie ^a   Wang, Gang ^a   Fu, Juanjuan ^c   Mao, Bing ^a  

^a SICHUAN UNIVERSITY   (China)

^b RUIKANG HOSPITAL AFFILIATED TO GUANGXI UNIVERSITY OF CHINESE MEDICINE   (China)

^c JOHN HUNTER HOSPITAL   (Australia)

Author keywords

CONSORT statement; Multi herb formulae; Parallel; Randomized controlled clinical trials; Reporting quality; Science citation index expanded

Indexed keywords

CHINESE MEDICINE; COMPUTERIZED ADAPTIVE TESTING; HERB; HUMAN; PRIORITY JOURNAL; REVIEW;

EID: 82455167979     PISSN: 18763820     EISSN: 18763839     Source Type: Journal    
DOI: 10.1016/j.eujim.2011.09.005     Document Type: Review

References (25)

1. Fønnebø V., Launsø L. High use of complementary and alternative medicine inside and outside of the government-funded health care system in Norway. J Altern Complement Med 2009, 15:1061-1066.
2. Brown C.M., Barner J.C., Richards K.M., Bohman T.M. Patterns of complementary and alternative medicine use in African Americans. J Altern Complement Med 2007, 13:751-758.
3. Gözüm S., Arikan D., Büyükavci M. Complementary and alternative medicine use in pediatric oncology patients in eastern Turkey. Cancer Nurs 2007, 30:38-44.
4. Yi Y.D., Chang I.M. An overview of traditional Chinese herbal formulae and a proposal of a new code system for expressing the formula titles. Evid Based Complement Alternat Med 2004, 1:125-132.
5. McKiernan G. Research Index: autonomous citation indexing on the web. Int J Grey Lit 2000, 1:41-46.
6. Leydesdorff L., Bihui J. Mapping the Chinese Science Citation Database in terms of aggregated journal-journal citation relations. J Am Soc Inf Sci Technol 2005, 56:1469-1479.
7. Schulz K.F., Altman D.G., Moher D. for the CONSORT Group. CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. Ann Intern Med 2010, 152:726-732.
8. Moher D., Hopewell S., Schulz K.F., Montori V., Gøtzsche P.C., Devereaux P.J., et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. J Clin Epidemiol 2010, 63:e1-e37.
9. Wu T.X., Li Y.P., Bian Z.X., LI T.Q., Li J., Simon D., et al. Consolidated Standards for Reporting Trials of Traditional Chinese Medicine (CONSORT for TCM) (For Solicitation of Comments). Chin J Evid Based Med 2007, 7:625-630.
10. Wang G., Mao B., Xiong Z.Y., Fan T., Chen X.D., Wang L., et al. The quality of reporting of randomized controlled trials of traditional Chinese medicine: a survey of 13 randomly selected journals from Mainland China. Clin Ther 2007, 29:1456-1467.
11. Gagnier J.J., DeMelo J., Boon H., Rochon P., Bombardier C. Quality of reporting of randomized controlled trials of herbal medicine interventions. Am J Med 2006, 119:e1-e11.
12. Zhong Y.Q., Fu J.J., Liu X.M., Diao X., Mao B., Fan T., et al. The reporting quality, scientific rigor, and ethics of randomized placebo-controlled trials of traditional Chinese medicine compound formulations and the differences between Chinese and non-Chinese trials. Curr Ther Res Clin Exp 2010, 71:30-49.
13. The CONSORT Group. CONSORT endorsers: journals. Available from: [accessed 06.11.10]. http://www.consort-statement.org/about-consort/supporters/consort-endorsers---journals/.
14. Landis J.R., Koch G.G. The measurement of observer agreement for categorical data. Biometrics 1977, 33:159-174.
15. Jüni P., Altman D.G., Egger M. Systematic reviews in health care: assessing the quality of controlled clinical trials. BMJ 2001, 323:42-46.
16. Rios L.P., Odueyungbo A., Moitri M.O., Rahman M.O., Thabane L. Quality of reporting of randomized controlled trials in general endocrinology literature. J Clin Endocrinol Metab 2008, 93:3810-3816.
17. Bridgman S., Engebretsen L., Dainty K., Kirkley A., Maffulli N., ISAKOS Scientific Committee Practical aspects of randomization and blinding in randomized clinical trials. Arthroscopy 2003, 19:1000-1006.
18. Eng J. Sample size estimation: how many individuals should be studied?. Radiology 2003, 227:309-313.
19. Charles P., Giraudeau B., Dechartres A., Baron G., Ravaud P. Reporting of sample size calculation in randomised controlled trials: review. BMJ 2009, 338:b1732.
20. Dwan K., Altman D.G., Arnaiz J.A., Bloom J., Chan A.W., Cronin E., et al. Systematic review of the empirical evidence of study publication bias and outcome reporting bias. PLoS One 2008, 3:e3081.
21. Chan A.W., Hróbjartsson A., Haahr M.T., Gøtzsche P.C., Altman D.G. Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles. JAMA 2004, 291:2457-2465.
22. Moher D., Jones A., Lepage L., CONSORT Group Use of the CONSORT statement and quality of reports of randomized trials: a comparative before-and-after evaluation. JAMA 2001, 285:1992-1995.
23. Zaslawski C. Clinical reasoning in traditional Chinese medicine: implications for clinical research. Clin Acupunct Orient Med 2003, 4:94-101.
24. Min Z.H., Zhou Y., Zhang H.M. Effect of treatment based on syndrome differentiation by Chinese medicine on post-traumatic elbow arthritis. Chin J Integr Med 2010, 16:264-269.
25. Junker C.A. Adherence to published standards of reporting: a comparison of placebo-controlled trials published in English or German. JAMA 1998, 280:247-249.